CTO - PbD BioTech

Joely Irlam-Jones

Joely Irlam-Jones

25 years' cancer research experience at the Christie Hospital and University of Manchester, 16 years’ experience in developing, validating, and delivering oncology biomarkers.

Technical expert in clinical biomarker platform discovery, co-founding university spin-out company ManTRa Diagnostics Ltd, served as CEO, to deliver a genomic test for precision cancer treatments and improved patient outcomes.

Involved in a steering group (Biomedical research Engagement Academic clinical healthcare – BREACH) to encourage academic/industrial engagement, helping to drive academic science across the translational gap for cancer patient benefit.